ArticleScientific reports2026
3D printed hydrogel scaffold incorporating keratin and melatonin-loaded nanomicelles for cartilage tissue engineering.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Articular cartilage possesses limited self-repair capacity due to its avascular nature, necessitating advanced tissue engineering strategies for effective regeneration. This study presents the fabrication and evaluation of a novel 3D-printed hydrogel scaffold composed of chitosan (Cs), carrageenan (Crg), and keratin (Kr), integrated with melatonin (Mel)-loaded nanomicelles to stimulate cartilage repair. The nanomicelles exhibited a mean diameter of 133.36 ± 13.69 nm, and their incorporation into the Cs-Crg/Kr-Mel scaffold enabled a sustained Mel release profile, reaching 88.0 ± 5.5% cumulative release over 264 h. The Cs-Crg/Kr-Mel scaffold demonstrated an equilibrium swelling ratio of 391.6 ± 26.3% after 72 h in distilled water and a degradation rate of 47.0 ± 5.5% after 28 days in PBS. In vitro assays using ATDC5 chondrogenic cells revealed superior cell viability and adhesion on the Mel-containing scaffold. Alcian blue and Safranin O staining confirmed increased proteoglycan synthesis of rBMSCs on the Cs-Crg/Kr-Mel scaffold and gene expression analysis via qRT-PCR indicated significantly elevated levels of COL II, ACAN, and SOX9, confirming enhanced chondrogenic differentiation. The combined presence of Kr and Mel contributed to the scaffold's regenerative efficacy by improving cell adhesion and modulating cellular processes involved in chondrogenic differentiation. These findings suggest that the Cs-Crg/Kr-Mel scaffold holds strong potential for application in cartilage repair and regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.